HK Stock MarketDetailed Quotes

LING YUI (00784)

Watchlist
  • 0.690
  • 0.0000.00%
Market Closed Apr 24 15:58 CST
552.00MMarket Cap-25.56P/E (TTM)

LING YUI (00784) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2025
(FY)Mar 31, 2025
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
Turnover
-24.20%91.41M
10.55%214.51M
8.77%120.59M
-18.80%194.04M
-12.51%110.86M
-30.59%238.96M
-22.59%126.72M
42.86%344.29M
49.76%163.7M
-46.76%240.99M
Operating income
-24.20%91.41M
10.55%214.51M
8.77%120.59M
-18.80%194.04M
-12.51%110.86M
-30.59%238.96M
-22.59%126.72M
42.86%344.29M
49.76%163.7M
-46.76%240.99M
Cost of sales
22.15%-82.01M
-10.95%-183.52M
-8.49%-105.34M
32.64%-165.41M
14.59%-97.1M
23.15%-245.55M
24.75%-113.68M
-43.95%-319.5M
-46.14%-151.08M
47.75%-221.95M
Operating expenses
22.15%-82.01M
-10.95%-183.52M
-8.49%-105.34M
32.64%-165.41M
14.59%-97.1M
23.15%-245.55M
24.75%-113.68M
-43.95%-319.5M
-46.14%-151.08M
47.75%-221.95M
Gross profit
-38.39%9.39M
8.22%30.99M
10.77%15.25M
534.49%28.64M
5.62%13.77M
-126.59%-6.59M
3.28%13.03M
30.19%24.79M
113.01%12.62M
-31.62%19.04M
Administrative expenses
4.57%-13.31M
-2.47%-28.34M
10.34%-13.95M
-0.96%-27.65M
-14.74%-15.56M
-27.75%-27.39M
-19.59%-13.56M
13.01%-21.44M
4.13%-11.34M
2.69%-24.64M
Impairment and provision
99.21%1.26M
-1,110,350.00%-22.21M
-41.99%634K
---2K
1,171.57%1.09M
----
87.80%-102K
2.40%-1.3M
-6,530.77%-836K
-448.15%-1.33M
-Other impairment is provision
99.21%1.26M
-1,110,350.00%-22.21M
-41.99%634K
---2K
1,171.57%1.09M
----
87.80%-102K
2.40%-1.3M
-6,530.77%-836K
-448.15%-1.33M
Special items of operating profit
748.59%3.62M
-48.50%736K
468.00%426K
-51.39%1.43M
-96.89%75K
22.65%2.94M
-5.05%2.41M
-74.13%2.4M
-65.25%2.54M
1,075.63%9.26M
Operating profit
-59.26%961K
-879.86%-18.82M
478.04%2.36M
107.77%2.41M
-135.02%-624K
-798.27%-31.04M
-40.26%1.78M
90.94%4.45M
111.26%2.98M
-24.02%2.33M
Financing cost
20.05%-650K
1.54%-1.73M
14.33%-813K
-4.39%-1.76M
-31.26%-949K
-23.10%-1.68M
23.57%-723K
38.29%-1.37M
11.42%-946K
7.47%-2.22M
Earning before tax
-79.88%311K
-3,237.25%-20.55M
198.28%1.55M
102.00%655K
-248.54%-1.57M
-1,163.44%-32.72M
-48.01%1.06M
2,672.07%3.08M
492.15%2.04M
-83.38%111K
Tax
----
----
----
----
----
420.55%2.68M
92.59%-40K
-26.63%-837K
-13,400.00%-540K
-73.95%-661K
After-tax profit from continuing operations
-79.88%311K
-3,237.25%-20.55M
198.28%1.55M
102.18%655K
-254.37%-1.57M
-1,441.03%-30.04M
-31.93%1.02M
507.27%2.24M
340.29%1.5M
-290.97%-550K
Earning after tax
-79.88%311K
-3,237.25%-20.55M
198.28%1.55M
102.18%655K
-254.37%-1.57M
-1,441.03%-30.04M
-31.93%1.02M
507.27%2.24M
340.29%1.5M
-290.97%-550K
Profit attributable to shareholders
-79.88%311K
-3,237.25%-20.55M
198.28%1.55M
102.18%655K
-254.37%-1.57M
-1,441.03%-30.04M
-31.93%1.02M
507.27%2.24M
340.29%1.5M
-290.97%-550K
Basic earnings per share
-78.95%0.0004
-3,312.50%-0.0257
195.00%0.0019
102.13%0.0008
-253.85%-0.002
-1,439.29%-0.0375
-31.58%0.0013
500.00%0.0028
375.00%0.0019
-275.00%-0.0007
Diluted earnings per share
-78.95%0.0004
-3,312.50%-0.0257
195.00%0.0019
0.0008
-253.85%-0.002
-31.58%0.0013
375.00%0.0019
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Sep 30, 2025(FY)Mar 31, 2025(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021
Turnover -24.20%91.41M10.55%214.51M8.77%120.59M-18.80%194.04M-12.51%110.86M-30.59%238.96M-22.59%126.72M42.86%344.29M49.76%163.7M-46.76%240.99M
Operating income -24.20%91.41M10.55%214.51M8.77%120.59M-18.80%194.04M-12.51%110.86M-30.59%238.96M-22.59%126.72M42.86%344.29M49.76%163.7M-46.76%240.99M
Cost of sales 22.15%-82.01M-10.95%-183.52M-8.49%-105.34M32.64%-165.41M14.59%-97.1M23.15%-245.55M24.75%-113.68M-43.95%-319.5M-46.14%-151.08M47.75%-221.95M
Operating expenses 22.15%-82.01M-10.95%-183.52M-8.49%-105.34M32.64%-165.41M14.59%-97.1M23.15%-245.55M24.75%-113.68M-43.95%-319.5M-46.14%-151.08M47.75%-221.95M
Gross profit -38.39%9.39M8.22%30.99M10.77%15.25M534.49%28.64M5.62%13.77M-126.59%-6.59M3.28%13.03M30.19%24.79M113.01%12.62M-31.62%19.04M
Administrative expenses 4.57%-13.31M-2.47%-28.34M10.34%-13.95M-0.96%-27.65M-14.74%-15.56M-27.75%-27.39M-19.59%-13.56M13.01%-21.44M4.13%-11.34M2.69%-24.64M
Impairment and provision 99.21%1.26M-1,110,350.00%-22.21M-41.99%634K---2K1,171.57%1.09M----87.80%-102K2.40%-1.3M-6,530.77%-836K-448.15%-1.33M
-Other impairment is provision 99.21%1.26M-1,110,350.00%-22.21M-41.99%634K---2K1,171.57%1.09M----87.80%-102K2.40%-1.3M-6,530.77%-836K-448.15%-1.33M
Special items of operating profit 748.59%3.62M-48.50%736K468.00%426K-51.39%1.43M-96.89%75K22.65%2.94M-5.05%2.41M-74.13%2.4M-65.25%2.54M1,075.63%9.26M
Operating profit -59.26%961K-879.86%-18.82M478.04%2.36M107.77%2.41M-135.02%-624K-798.27%-31.04M-40.26%1.78M90.94%4.45M111.26%2.98M-24.02%2.33M
Financing cost 20.05%-650K1.54%-1.73M14.33%-813K-4.39%-1.76M-31.26%-949K-23.10%-1.68M23.57%-723K38.29%-1.37M11.42%-946K7.47%-2.22M
Earning before tax -79.88%311K-3,237.25%-20.55M198.28%1.55M102.00%655K-248.54%-1.57M-1,163.44%-32.72M-48.01%1.06M2,672.07%3.08M492.15%2.04M-83.38%111K
Tax --------------------420.55%2.68M92.59%-40K-26.63%-837K-13,400.00%-540K-73.95%-661K
After-tax profit from continuing operations -79.88%311K-3,237.25%-20.55M198.28%1.55M102.18%655K-254.37%-1.57M-1,441.03%-30.04M-31.93%1.02M507.27%2.24M340.29%1.5M-290.97%-550K
Earning after tax -79.88%311K-3,237.25%-20.55M198.28%1.55M102.18%655K-254.37%-1.57M-1,441.03%-30.04M-31.93%1.02M507.27%2.24M340.29%1.5M-290.97%-550K
Profit attributable to shareholders -79.88%311K-3,237.25%-20.55M198.28%1.55M102.18%655K-254.37%-1.57M-1,441.03%-30.04M-31.93%1.02M507.27%2.24M340.29%1.5M-290.97%-550K
Basic earnings per share -78.95%0.0004-3,312.50%-0.0257195.00%0.0019102.13%0.0008-253.85%-0.002-1,439.29%-0.0375-31.58%0.0013500.00%0.0028375.00%0.0019-275.00%-0.0007
Diluted earnings per share -78.95%0.0004-3,312.50%-0.0257195.00%0.00190.0008-253.85%-0.002-31.58%0.0013375.00%0.0019
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More